Temasek-backed Chinese biotech firm D3 Bio raises $62m in Series A+ round : vimarsana.com

European life sciences investment firm Medicxi led the round with a $40 million investment.

Related Keywords

Boyu , Xizang , China , Hongshan , Jiangxi , Shanghai , Chinese , Daiichi Sankyo , George Chen , Antoine Yver , Novartis , Alphabet Inc , Johnson , Astrazeneca , Temasek , Singapore Temasek Holdings , Temasek Holdings , Boyu Capital , Matrix Partners China , Wuxi Apptec , Wuxi Apptech , Sequoia Capital ,